Browsing by Author "Vidal, A."
Now showing 1 - 6 of 6
Results Per Page
Sort Options
- Are Portuguese population exposed to Zearalenone? A human biomonitoring study as a contribution to the risk assessment of an endocrine disruptorPublication . Martins, Carla; Vidal, A.; De Saeger, Sarah; Assunção, R.; Nunes, Carla; Torres, D.; Goios, A.; Lopes, Carla; Alvito, P.; De Boevre, MartheZearalenone (ZEN) is a mycotoxin that occurs widely in food commodities with particular incidence in cereals. Due to chemical structures similar to the endogenous oestrogen 17-β-estradiol, ZEN and its metabolites exert estrogenic toxicity. Therefore, it is crucial to assess ZEN exposure among the population and biomarker-driven research is a promising method to assess the human exposure. For this reason, ZEN metabolites such as α-zearalenol (α-ZEL), β-zearalenol (β-ZEL), α-zearalenal (α-ZAL), β-zearalenal (β-ZAL), zearalanone (ZAN) (phase I) and the glucuronides ZEN14GlcA, α-ZEL14GlcA and β-ZEL14Glc (phase II) were identified in biological fluids. With a potency factor of 60 relative to ZEN, α-ZEL is the most relevant metabolite in terms of human health. ZEN is characterized by a fast metabolism and excretion, therefore urine is the matrix commonly used to assess the exposure to this mycotoxin and its metabolites. To date, in Portugal, there is a lack of human studies to assess biomarkers of exposure to ZEN. Within the Scope of National Food, Nutrition, and Physical Activity Survey of the Portuguese General Population (2015-2016), 24h-urine samples and non-consecutive dietary assessments (two 24-hour recalls, 8-15 days apart) from 94 participants were included in the present study. Following a salt-assisted matrix extraction, urine samples were analyzed using LC-MS/MS for the simultaneous determination of ZEN, α-ZEL, β-ZEL, α-ZAL, β-ZAL, ZAN and ZEN14GlcA. ZEN and ZEN-14-GlcA were detected in 52% (36/69) and 14% (10/69) of the analyzed samples, with a mean concentration of 1.2 and 6.9 µg/L, respectively. The metabolites α-ZEL, β-ZEL, α-ZAL, β-ZAL, ZAN were not detected in the urine samples. Considering the 24h-urinary volume, the mean dietary excretion of ZEN and ZEN-14-GlcA was 1.5 and 7.8 µg/day, respectively. These data will allow the determination of Probably Daily Intake of zearalenone with more accuracy since it reflects the internal exposure of participants.
- earlyMYCO – a mother & child cohort in PortugalPublication . Assunção, Ricardo; Martins, Carla; Costa, A.; Serrano, D.; De Boevre, Marthe; Vidal, A.; De Saeger, Sarah; Alvito, Paula; Vidigal, C.; Almeida, E.; Nunes, C.Background: Early-life exposure occurs during gestation through transfer of toxic substances present in the maternal diet to the fetus and later on, during lactation, through the breast milk. Food chemical contaminants as mycotoxins are well known carcinogenic, nephrotoxic, hepatotoxic and immunosuppressive compounds. Recent human biomonitoring data revealed that Portuguese population is exposed to mycotoxins. These results emphasized the need for assessing the prenatal and lactation exposure to mycotoxins in a critical and vulnerable period of life. This study aims for the first time in Portugal to assess the early-life exposure to mycotoxins through a mother & child cohort, thus contributing to the knowledge of the exposome of Portuguese population. Methods: Participants are recruited in primary health care units in Lisbon (Portugal) during pregnancy (1st trimester). Four moments of observation are expected within this study: 2nd trimester of pregnancy (mother), and 1st week of life, 1st month of life, 6th month (mother & child). Each moment includes the collection of biological samples (blood, urine, breast milk) and the application of sociodemographic and food consumption questionnaires. Biological samples will be analyzed by liquid chromatography with detection by mass spectrometry for the detection and quantification of 45 mycotoxins’ biomarkers. Results: Data presented include results of mycotoxins’ biomarkers from 12 participants for blood and urine samples. Results obtained will be used to estimate the probable daily intake of each mycotoxin, to perform risk characterization and estimate the burden associated with this exposure. Conclusions: It is expected that results obtained within earlyMYCO will contribute to have a deeper knowledge on exposure of vulnerable population groups (pregnant women and infants) and to understand the impact of early-life exposure to mycotoxins. The biobank will be available for further research and future studies will be developed in order to have a broader knowledge on the exposome of Portuguese population.
- earlyMYCO project - Early-life exposure to mycotoxins: a neglected issue?Publication . Alvito, Paula; Amador, P.; Broeiro, Paula; Caldeira, T; De Boevre, Marthe; De Saeger, Sarah; Duarte, E.; Ferreira, M.; Lamy, Elisabete; Mexia, R.; Namorado, S.; Nunes, B.; Nunes, C.; Pires, S.; Silva, M.J.; Silva, Susana; Vidal, A.; Martins, C.; Assunção, R.Recent studies under MYCOMIX project reported that Portuguese children until 3 years old are exposed to multiple mycotoxins through food consumption, constituting a potential health threat. Aflatoxins (carcinogenic toxins) represented the main risk contributors and deoxynivalenol (a non-carcinogenic toxin associated with immunological and gastrointestinal toxic effects) showed the highest daily intake of the studied mycotoxins. These results opened new research perspectives and emphasized the need to accurately assess the prenatal and lactational exposure to mycotoxins in a critical and vulnerable period of life. Early-life exposure of children occurs during gestation through transfer of toxic substances present in the maternal diet to the fetus and later on, during lactation, through the breast milk. Considering this, the national project earlyMYCO – Early-life exposure to MYCOtoxins and its impact on health aims at assessing the risk of early-life exposure to mycotoxins. earlyMYCO proposes to answer several key questions including what extent are pregnant women and infants until six months exposed to mycotoxins in Portugal? Is this exposure a health threat? With this purpose, earlyMYCO gathered a multidisciplinar team with expertise on medical sciences, public health and toxicology to perform i) an epidemiological study, including the recruitment of pregnant women and infants, food survey and biological sample collection and ii) mycotoxin exposure assessment in pregnant women and infants using biomarkers of exposure. The epidemiological study was approved by INSA’s Ethical Committee and will be conducted in the Primary Health Care of Central Lisboa. The biomonitoring study will use advanced analytical methodologies and will provide data to perform the exposure assessment. Due to the increasing prevalence in food commodities, mycotoxins appear to be important, but often neglected contaminants in terms of health impact on human population especially in vulnerable groups as children. It is expected that results obtained within earlyMYCO will contribute to understand the impact of mycotoxin early-life exposure.
- Exposure assessment of Portuguese population to multiple mycotoxins: the human biomonitoring approachPublication . Martins, Carla; Vidal, A.; De Boevre, M.; De Saeger, S.; Nunes, C.; Torres, D.; Goios, A.; Lopes, C.; Assunção, R; Alvito, P.Mycotoxins constitute a relevant group of food contaminants with several associated health outcomes such as estrogenic, immunotoxic, nephrotoxic and teratogenic effects. Although scarce data are available in Portugal, human biomonitoring studies have been globally developed to assess the exposure to mycotoxins at individual level. In order to overcome this lack of data, the present study concerned the analysis of mycotoxins in 24h urine and first-morning urine paired samples from 94 participants enrolled within the scope of the National Food, Nutrition, and Physical Activity Survey of the Portuguese General Population (2015–2016). Following a salt assisted matrix extraction, urine samples were analysed by liquid chromatography–mass spectrometry for the simultaneous determination of 37 urinary mycotoxins’ biomarkers and data obtained used to estimate the probable daily intake as well as the risk characterization applying the Hazard Quotient approach. Results revealed the exposure of Portuguese population to zearalenone, deoxynivalenol, ochratoxin A, alternariol, citrinin and fumonisin B1 through the quantification in 24h urine and first-morning urine paired samples. Risk characterization data revealed a potential concern to some reported mycotoxins since the reference intake values were exceeded by some of the considered participants. Alternariol was identified for the first time in urine samples from a European country; however, risk characterization was not performed due to lack of reference intake value. These results confirmed mycotoxins as part of the human exposome of the Portuguese population reinforcing the need for further studies regarding the determinants of exposure.
- Exposure of Portuguese population to mycotoxins: the contribution of human biomonitoring studiesPublication . Martins, C.; De Boevre, M.; De Saeger, S.; Assunção, R.; Nunes, Carla; Torres, D.; Goios, A.; Lopes, C.; Alvito, P.; Vidal, A.Mycotoxins are secondary metabolites produced by fungi that occurs widely in food commodities, and are known to potentially cause toxicity and carcinogenic outcomes to humans. Therefore, it is crucial to assess the population exposure to mycotoxins. Biomarker-driven research appeared as a promising method to assess the mycotoxin exposure in humans. To date, in Portugal, there is a lack of human studies to assess biomarker of exposure to mycotoxins. In the Scope of National Food, Nutrition, and Physical Activity Survey of the Portuguese General Population (2015-2016), a cross-sectional study was developed based on a convenience sample of 94 participants. Participants were from both genders, aged 18-84 years, from north and center regions of Portugal, and collected 24h urine samples. Analytical determination of mycotoxins urinary biomarkers (n = 40) was performed by liquid chromatography coupled to a mass spectrometer detector. Preliminary results showed that exposure of Portuguese population to mycotoxins is a reality. Until now, results revealed the presence of seven mycotoxins and metabolites in 10% to 76% of analyzed samples. Considering the 24h-urinary volume, mean dietary excretion of deoxynivalenol (DON) and zearalenone (ZEN) was 35.8 and 1.9 mg/day, respectively. Regarding DON, results showed a good correlation between excreted biomarkers: DON-DON3GlcA (r = 0.7322) and DON-DON15GlcA (r = 0.7538), confirming the adequacy of these biomarkers. Further analysis regarding the excretion of other mycotoxins are still in course. This biomonitoring study generate, for the first time, reliable data regarding the exposure of Portuguese population to mycotoxins. These data are crucial to perform a more realistic risk assessment, contribute to the knowledge of determinants of this exposure and provides evidence-based data to support the revision of legislative limits concerning the occurrence of mycotoxins in food. Key messages: Portuguese population is exposed to mycotoxins, chemical food contaminants that may be harmful (carcinogenic, immunotoxic, mutagenic, teratogenic, hepatotoxic) for human health; Human biomonitoring studies provide realistic data on internal exposure at individual level, allowing a more accurate knowledge of the determinants of exposure to these contaminants.
- Human biomonitoring of multiple mycotoxins in the Portuguese population: strengths and limitations under risk assessmentPublication . Martins, Carla; De Boevre, Marthe; De Saeger, Sarah; Nunes, Carla; Torres, Duarte; Goios, A.; Lopes, Carla; Assunção, Ricardo; Alvito, Paula; Vidal, A.Mycotoxins constitute a relevant group of food contaminants with associated health outcomes such as estrogenic, immunotoxic, nephrotoxic and teratogenic effects. Although scarce data are available in Portugal, human biomonitoring (HBM) studies have been globally developed to assess the exposure to mycotoxins at individual level. This study aimed to present data for mycotoxins’ urinary biomarkers within a human biomonitoring study developed to assess the exposure of the Portuguese population, and to characterize the risk associated to the exposure. In the scope of the National Food, Nutrition, and Physical Activity Survey of the Portuguese General Population (2015-2016), 24h-urine samples from 94 participants were analyzed by liquid chromatography–mass spectrometry (LC-MS/MS) for the simultaneous determination of 37 mycotoxins’ urinary biomarkers. Data obtained were used to estimate the probable daily intake as well as the risk characterization applying multiple imputation, reverse dosimetry and hazard quotient approaches. Results revealed the exposure of Portuguese population to zearalenone, deoxynivalenol, ochratoxin A, alternariol, citrinin and fumonisin B1. Risk characterization data revealed a potential concern to some reported mycotoxins since the reference intake values were exceeded by some of the considered participants. The use of data at individual level, the collection of 24h urine samples, the performance of analytical method and the use of multiple imputation approach were identified as the main strengths of this study. The limitations identified were related with the use of excretion data obtained within animal studies and the absence of health based guidance values for urinary biomarkers that would allow a direct comparison. The present study generated, for the first time and within a HBM study, reliable data on internal exposure to multiple mycotoxins at individual level for the Portuguese population. These data contributes for supporting risk managers in the establishment of preventive policy measures to ensure public health protection.